ARRO-MARK CO. LLC v. WARREN

CourtDistrict Court, D. New Jersey
DecidedMarch 28, 2024
Docket2:22-cv-06663
StatusUnknown

This text of ARRO-MARK CO. LLC v. WARREN (ARRO-MARK CO. LLC v. WARREN) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
ARRO-MARK CO. LLC v. WARREN, (D.N.J. 2024).

Opinion

NOT FOR PUBLICATION

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY

ARRO-MARK CO. LLC.,

Plaintiff,

v. Case No.: 2:22-cv-6663-JKS-MAH

CEDRIC WARREN (individually), MICHAEL MAMARY (individually), WHEREAS OPINION AND ORDER SKM INDUSTRIES, INC., SHANTA SYAL (individually), AND JOHN DOE 1-10 AND ABC CORPORATIONS 1- March 28, 2024 10 (being fictitious names of persons and entities who are not presently known to Plaintiff),

Defendants. SEMPER, District Judge. THIS MATTER comes before the Court upon the filing of Plaintiff Arro-Mark Co. LLC’s Renewed Order to Show Cause (ECF 145), which seeks (1) to hold Defendants SKM Industries Inc. (“SKM”) and Shanta Syal (“Syal”) (together, “Defendants”) in contempt of court for violating this Court’s December 20, 2022 Consent Order (ECF 26) and (2) to enjoin Defendants from infringing upon Plaintiff’s trademarks. The Court considered Plaintiff’s and Defendants’ submissions1 and held oral argument on March 27, 2024; and WHEREAS Plaintiff is a closely held business engaged in manufacturing and producing inks and paints for permanent marking devices for sale in interstate commerce. (Pl. Br. at 3.) SKM

1 Plaintiff’s memorandum of law in support of its application (ECF 145-1) is referred to as “Pl. Br.” Defendants’ Opposition to Plaintiff’s application (ECF 148) is referred to as “Opp.” Plaintiff’s Reply (ECF 151) is referred to as “Reply.” does business in the same industry. (Opp. at 32-33.) “[T]he parties’ have had a long-standing relationship, and [Defendant] SKM has used the subject trademarks on Arro-Mark products for several years[.]” (Opp. at 24.) The relationship deteriorated, and Plaintiff filed suit alleging, among other things, trademark infringement and misappropriation of trade secrets. (ECF 1, 123.)

WHEREAS Plaintiff seeks to hold Defendants in contempt of court for violating this Court’s December 20, 2022 Consent Order. To establish civil contempt, the movant must show by clear and convincing evidence that (1) a valid court order existed; (2) defendants had knowledge of the order; and (3) defendants disobeyed the order. Harris v. City of Phila., 47 F.3d 1311, 1326 (3d Cir. 1995); Roe v. Operation Rescue, 919 F.2d 857, 871 (3d Cir. 1990). The Consent Order states, as relevant here, 1. Defendants Warren, Mamary, SKM and Shanta shall not market, produce, distribute, sell or advertise products using or bearing the term “Muscle Man” in written form, word or image and they shall make reasonable efforts to take down current advertising related thereto . . .

5. Defendants Warren, Mamary, SKM and Shanta shall not market, produce, distribute and/or otherwise sell any of Plaintiff’s trade secrets;

(ECF 26 ¶¶ 1, 5.) Plaintiff asserts Defendants violated Paragraph 1 of the Consent Order by marketing products bearing the term “Muscle Man.” (Pl. Br. at 10-13.) Plaintiff asserts Defendants violated Paragraph 5 by creating a nib catalog that copied Plaintiff’s nib catalog, using Plaintiff’s distributor price list to undercut Plaintiff’s pricing in the marketplace, and misappropriating Plaintiff’s customer list to market Defendants’ products to Plaintiff’s customers. (Id. at 13-15.) WHEREAS a defendant should not be found in contempt of an order if there is reason to doubt the wrongfulness of defendant’s conduct. Harris, 47 F.3d at 1326 (citing Quinter v. Volkswagen of Am., 676 F.2d 969, 974 (3d Cir. 1982)). The resolution of any ambiguities should favor the party charged with contempt. Harris, 47 F.3d at 1326. Defendants assert they did not violate Paragraph 1 of the Consent Order because they “have not produced, distributed, sold, or advertised ‘Muscle Man’ product since entry of the Consent Order, and indeed removed all current advertising related thereto.” (Opp. at 8-9.) Further, Defendants assert Plaintiff relies on alleged instances of marketing or advertising that occurred prior to the entry of the Consent Order,

highlighting the dates contained in the URLs. (Id. at 9-11.) Given the ambiguities surrounding the Defendants’ conduct, see Harris, 47 F.3d at 1326, the Court finds Defendants did not violate Paragraph 1 of the Consent Order. WHEREAS Defendants assert they did not violate Paragraph 5 of the Consent Order and argue Plaintiff’s allegations are based entirely upon speculation and inference. (Opp. at 13-14.) For example, in its brief, Plaintiff states “SKM Defendants are believed to possess Arro-Mark’s distributor price list” and “it can reasonably be inferred that SKM and Syal have misappropriated Arro-Mark’s customer list . . . .” (Pl. Br. at 13-14 (emphasis added).) Defendants argue, in the alternative, that even if these allegations were true, such conduct would have taken place prior to the entry of the Consent Order and could not form the basis for a finding of contempt. (Id. at 14.)

Because there is sufficient reason to doubt the wrongfulness of Defendants’ conduct, see Harris, 47 F.3d at 1326, the Court agrees with Defendants and finds Defendants did not violate Paragraph 5 of the Consent Order. Accordingly, the Court declines to find Defendants in contempt or issue sanctions against Defendants.2 WHEREAS Plaintiff seeks to “enjoin[] Defendants from marketing, producing, distributing, and/or otherwise profiting from the misappropriation of Plaintiff’s trademarks.” (Pl.

2 Although this case was filed in November of 2022, the parties have engaged in limited discovery thus far. Plaintiff asked this Court “to order the Defendants SKM and Shanta turn over all electronic devices to Plaintiff’s forensic expert who will make a copy of the hard drive for purposes of learning what other emails have been exchanged concerning misappropriation of Plaintiff’s proprietary information.” (Pl. Br. at 17.) Plaintiff’s briefs did not cite to any legal authority to support its request for this extreme measure. Accordingly, the Court denies Plaintiff’s request. Br. at 18.) Preliminary injunctive relief “is an ‘extraordinary remedy, which should be granted only in limited circumstances.’” Ferring Pharms., Inc. v. Watson Pharms, Inc., 765 F.3d 205, 210 (3d Cir. 2014) (quoting Novartis Consumer Health, Inc. v. Johnson & Johnson-Merck Consumer Pharms. Co., 290 F.3d 578, 586 (3d Cir. 2002)). To obtain a preliminary injunction, “[t]he moving

party must demonstrate, first, a likelihood of success on the merits, and second, that ‘it is more likely than not to suffer irreparable harm in the absence of preliminary relief.’” Mallet & Co. v. Lacayo, 16 F.4th 364, 380 (3d Cir. 2021) (quoting Reilly v. City of Harrisburg, 858 F.3d 173, 179 (3d Cir. 2017) (footnote omitted)). If both factors are established, a court will consider two remaining factors: whether granting relief will result in even greater harm to the nonmoving party or other interested persons and whether the public interest favors such relief. Mallet & Co., 16 F.4th at 380. “[T]he failure to establish any element renders a preliminary injunction inappropriate.” Ferring Pharms., Inc., 765 F.3d at 210 (quoting NutraSweet Co. v. Vit-Mar Enters., Inc., 176 F.3d 151, 153 (3d Cir. 1999) (internal punctuation omitted)).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
ARRO-MARK CO. LLC v. WARREN, Counsel Stack Legal Research, https://law.counselstack.com/opinion/arro-mark-co-llc-v-warren-njd-2024.